According to this rationale, the primary difference between schistosomiasis and diseases resulting from a "rogue" CD4+ T-cell response is the location of the target epitope, whether in the liver, pancreas, skin, intestine, or brain. This evidence concerns the gene CD4 and schistosomiasis.